User:Mr. Ibrahem/Dofetilide
 | |
| Clinical data | |
|---|---|
| Trade names | Tikosyn |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a601235 |
| Drug class | Class III antiarrhythmic agent[1] |
| Pharmacokinetic data | |
| Bioavailability | 96% (by mouth) |
| Protein binding | 60% -70% |
| Elimination half-life | 10 hours |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C19H27N3O5S2 |
| Molar mass | 441.56 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Dofetilide, sold under the brand name Tikosyn, is a medication used to keep people with atrial fibrillation or atrial flutter in sinus rhythm.[1] It is only indicated in those who have been in an abnormal rhythm for more than a week and have significant symptoms.[2] It is taken by mouth.[1]
Common side effects include headache, chest pain, and dizziness.[1] Other side effects may include QT prolongation and potentially an increased risk of death.[1] It should not be used in people with severe kidney problems.[1] Safety in pregnancy is unclear.[1] It is a class III antiarrhythmic agent.[1]
Dofetilide was approved for medical use in the United States in 1999.[1] While it was approved in Europe in 1999, this was withdrawn in 2004.[3] In the United States it costs about 25 USD per month.[4]
References[edit]
- ^ a b c d e f g h i j k "Dofetilide Monograph for Professionals". Drugs.com. Archived from the original on 10 August 2020. Retrieved 26 December 2021.
- ^ "DailyMed - DOFETILIDE capsule". dailymed.nlm.nih.gov. Archived from the original on 11 January 2022. Retrieved 26 December 2021.
- ^ "Tikosyn". Archived from the original on 11 January 2022. Retrieved 26 December 2021.
- ^ "Dofetilide Prices and Dofetilide Coupons - GoodRx". GoodRx. Archived from the original on 5 November 2016. Retrieved 26 December 2021.